These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 19893359

  • 1. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP, Nambiar A.
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y, Li W, Liu N, Zhang K, Gong Z, Li D, Wang L, Wang D, Jing Y, Wang J, Shan X.
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS, Franz JM, Jobim MS, Arend A, Merzoni J, Cardone JM, Gil B, Sekine L, Jobim LF.
    Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
    [Abstract] [Full Text] [Related]

  • 5. Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response.
    Thuku NW, Shikuku K, Mbugua A.
    Pan Afr Med J; 2017 May; 27():226. PubMed ID: 28979628
    [Abstract] [Full Text] [Related]

  • 6. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K, Löwenberg B.
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM, Blumberg N, Masel D.
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [Abstract] [Full Text] [Related]

  • 8. The use of a potential novel tool in virtual crossmatching for platelet transfusion in platelet refractoriness.
    Bub CB, Gonçalez AC, Barjas-Castro ML, Sousa LC, do Monte SJ, Castro V.
    Vox Sang; 2016 Jan; 110(1):70-8. PubMed ID: 26274830
    [Abstract] [Full Text] [Related]

  • 9. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
    Xia WJ, Ye X, Tian LW, Xu XZ, Chen YK, Luo GP, Bei CH, Deng J, Santoso S, Fu YS.
    Transfus Med; 2010 Aug 01; 20(4):269-74. PubMed ID: 20136782
    [Abstract] [Full Text] [Related]

  • 10. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD, van der Holt B, de Veld JC, Gratama JW, de Vries W, van't Veer MB.
    Vox Sang; 2004 Nov 01; 87(4):291-8. PubMed ID: 15585026
    [Abstract] [Full Text] [Related]

  • 11. Platelet crossmatch testing for donor selection.
    Slichter SJ.
    Prog Clin Biol Res; 1982 Nov 01; 88():153-64. PubMed ID: 7100207
    [Abstract] [Full Text] [Related]

  • 12. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
    Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM.
    Transfusion; 2000 Dec 01; 40(12):1446-56. PubMed ID: 11134563
    [Abstract] [Full Text] [Related]

  • 13. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
    Desai P, Sontakke P, Rajadhyaksha S, Navkudkar A.
    Transfus Apher Sci; 2020 Oct 01; 59(5):102842. PubMed ID: 32586771
    [Abstract] [Full Text] [Related]

  • 14. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH, Chow MP, Hu HY, Tzeng JL, Mou LL, Deng JM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr 01; 47(4):228-36. PubMed ID: 1646671
    [Abstract] [Full Text] [Related]

  • 15. How do I … manage the platelet transfusion-refractory patient?
    Juskewitch JE, Norgan AP, De Goey SR, Duellman PM, Wakefield LL, Gandhi MJ, Stubbs JR, Kreuter JD.
    Transfusion; 2017 Dec 01; 57(12):2828-2835. PubMed ID: 28960321
    [Abstract] [Full Text] [Related]

  • 16. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P, Petz LD, Scott EP, Santos S.
    Br J Haematol; 1984 Jun 01; 57(2):337-47. PubMed ID: 6375714
    [Abstract] [Full Text] [Related]

  • 17. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS, Ness PM, Braine HG.
    Am J Clin Pathol; 1988 Jul 01; 90(1):69-72. PubMed ID: 3389345
    [Abstract] [Full Text] [Related]

  • 18. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul 01; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T, Wolf JL, Mraz L, Scott EP, Patz LD.
    JAMA; 1982 Nov 12; 248(18):2301-3. PubMed ID: 6752444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.